System and methods for performing saliva-based diagnostic screenings
US-2024420847-A1 · Dec 19, 2024 · US
ASC as a marker for chronic obstructive pulmonary disease (COPD)
US9116156B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9116156-B2 |
| Application number | US-201314022273-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 10, 2013 |
| Priority date | Mar 11, 2011 |
| Publication date | Aug 25, 2015 |
| Grant date | Aug 25, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
An in vitro method aiding in the assessment of chronic obstructive pulmonary disease (COPD). The disclosure further relates to a method for assessing COPD from a sample, derived from an individual, by measuring the protein ASC in said sample in vitro.
First claim
Opening claim text (preview).
What is claimed is: 1. An in vitro method for diagnosing chronic obstructive pulmonary disease (COPD) in a patient, comprising: determining a concentration of protein apoptosis-associated speck-like protein containing a caspase-associated recruitment domain (ASC) in a serum, plasma, or whole blood sample obtained from the patient, wherein said step of determining comprises: contacting a portion of the sample obtained from the patient with an antibody that specifically binds to p…
Assignees
Inventors
Classifications
Physics · mapped topic
- G01N33/6893Primary
Physics · mapped topic
- G01N33/6884Primary
Physics · mapped topic
Physics · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9116156B2 cover?
- An in vitro method aiding in the assessment of chronic obstructive pulmonary disease (COPD). The disclosure further relates to a method for assessing COPD from a sample, derived from an individual, by measuring the protein ASC in said sample in vitro.
- Who is the assignee on this patent?
- Roche Diagnostics Operations
- What technology area does this patent fall under?
- Primary CPC classification G01N33/6893. Mapped technology areas include Physics.
- When was this patent published?
- Publication date Tue Aug 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).